Focal segmental glomerulosclerosis (NORD)

Last updated: February 23, 2023

Focal segmental glomerulosclerosis (NORD)

Watch later

Watch later

Multiple endocrine neoplasia
Seronegative and septic arthritis: Pathology review
Primary sclerosing cholangitis
Papulosquamous and inflammatory skin disorders: Pathology review
Bleeding disorders: Clinical
Nephritic and nephrotic syndromes: Clinical
Nephrotic syndromes: Pathology review
Nephritic syndromes: Pathology review
Aortic dissections and aneurysms: Pathology review
Reactive arthritis
Seronegative arthritis: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Rheumatoid arthritis: Clinical
Systemic lupus erythematosus (SLE): Pathology review
MEN syndromes: Clinical
Leg ulcers: Clinical
Breast cancer: Pathology review
Parkinson disease
Non-Hodgkin lymphoma
Lymphomas: Pathology review
Lymphoma: Clinical
Cushing syndrome
Cushing syndrome: Clinical
Cushing syndrome and Cushing disease: Pathology review
Cirrhosis: Clinical
Physiological changes during exercise
Role of Vitamin K in coagulation
Clot retraction and fibrinolysis
Thrombotic thrombocytopenic purpura
Thrombocytopenia: Clinical
Hemophilia
Coagulation disorders: Pathology review
Chronic leukemia
Anemia of chronic disease
Peripheral artery disease: Pathology review
Peripheral vascular disease: Clinical
Dermatomyositis
Myalgias and myositis: Pathology review
Hypocalcemia
Hypercalcemia
Hypokalemia
Hypernatremia
Hypernatremia: Clinical
Hyponatremia: Clinical
Hypokalemia: Clinical
Hypomagnesemia
Miscellaneous hypoglycemics
Insulins
Renal artery stenosis
Antiplatelet medications
Macrocytic anemia: Pathology review
Microcytic anemia: Pathology review
Acneiform skin disorders: Pathology review
Staphylococcus aureus
Streptococcus pyogenes (Group A Strep)
Herpes simplex virus
Chronic kidney disease
Vitamin B12 deficiency
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Goodpasture syndrome
Myelodysplastic syndromes
Sjogren syndrome
Sjogren syndrome: Pathology review
Sjogren syndrome: Clinical
Psoriasis
Crohn disease
Acute pyelonephritis
Chronic pyelonephritis
Hypoglycemics: Insulin secretagogues
Gout
Gout and pseudogout: Pathology review
Ulcerative colitis
Inflammatory bowel disease: Clinical
Celiac disease
DNA alkylating medications
Chronic kidney disease: Clinical
Hidradenitis suppurativa
ACE inhibitors, ARBs and direct renin inhibitors
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Bone tumors
Pediatric bone tumors: Clinical
Bone tumors: Pathology review
Developmental dysplasia of the hip
Venous thromboembolism: Clinical
Carpal tunnel syndrome
Heart failure
Thiazide and thiazide-like diuretics
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Positive inotropic medications
Hyperthyroidism
Hyperthyroidism: Pathology review
Lichen planus
Viral hepatitis: Clinical
Hepatitis medications
Viral hepatitis: Pathology review
Autoimmune hepatitis
Pleural effusion: Clinical
Hyperthyroidism medications
Hypothyroidism medications
Rotator cuff tear
Anatomy clinical correlates: Clavicle and shoulder
Breast cancer: Clinical
Osteomalacia and rickets
Pelvic inflammatory disease
Mastocytosis (NORD)
Hernias: Clinical
Abdominal hernias
von Hippel-Lindau disease
PDE5 inhibitors
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Pemphigus vulgaris
Polycystic ovary syndrome
Miscellaneous lipid-lowering medications
Monoclonal antibodies
Osteoarthritis
Rheumatoid arthritis and osteoarthritis: Pathology review
Cytokines
Glucocorticoids
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Platelet disorders: Pathology review
Deep vein thrombosis
Pulmonary embolism
Thrombophlebitis
Opioid agonists, mixed agonist-antagonists and partial agonists
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Heparin
Heparin-induced thrombocytopenia
Peripheral artery disease
Focal segmental glomerulosclerosis (NORD)
Minimal change disease
Membranous nephropathy
Poststreptococcal glomerulonephritis
IgA nephropathy (NORD)
Membranoproliferative glomerulonephritis
Rapidly progressive glomerulonephritis
Anticonvulsants and anxiolytics: Benzodiazepines
Diverticulosis and diverticulitis
Sarcoidosis
Acute leukemia
Vasculitis
Primary biliary cholangitis
Hyperkalemia
Jaundice
Stevens-Johnson syndrome
Osteoporosis medications
General anesthetics
Selective serotonin reuptake inhibitors
Systemic lupus erythematosus (SLE): Clinical
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus and SIADH: Pathology review
Hepatic encephalopathy
Osteomyelitis
Fibromyalgia
Cell-mediated immunity of natural killer and CD8 cells
Ankylosing spondylitis
Septic arthritis
Hyperparathyroidism
Parathyroid conditions and calcium imbalance: Clinical
Heart failure: Clinical
Cardiomyopathies: Pathology review
Cardiomyopathies: Clinical
Gastrointestinal bleeding: Pathology review
Acute pancreatitis
Pancreatitis: Clinical
Pancreatitis: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Gastroesophageal reflux disease (GERD)
Peptic ulcers and stomach cancer: Clinical
Gastric cancer
Colorectal polyps
Colorectal cancer
Colorectal polyps and cancer: Pathology review
Colorectal cancer: Clinical
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Pediatric infectious rashes: Clinical
Parathyroid disorders and calcium imbalance: Pathology review
Phosphate, calcium and magnesium homeostasis
Obstructive lung diseases: Pathology review
Fever of unknown origin: Clinical
Malabsorption: Clinical
Neurocutaneous disorders: Pathology review
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Acute kidney injury: Clinical
Neisseria gonorrhoeae
Non-urothelial bladder cancers
Alopecia: Clinical
Esophageal disorders: Clinical
Esophageal disorders: Pathology review
Esophageal surgical conditions: Clinical
Peptic ulcer
Porphyria cutanea tarda
Acute intermittent porphyria
Myocardial infarction
Hypopigmentation skin disorders: Clinical
Subdural hematoma
Alport syndrome
Bullous pemphigoid
Thyroid nodules and thyroid cancer: Clinical
Pheochromocytoma
Kidney stones: Clinical
Asthma: Clinical
Pneumonia: Pathology review
Pneumonia: Clinical
Diarrhea: Clinical
Jaundice: Pathology review
Restrictive lung diseases: Pathology review
Renal failure: Pathology review

Transcript

Watch video only

Content Reviewers

Focal segmental glomerulosclerosis, or sometimes focal glomerular sclerosis, or just sometimes FSGS, is a type of kidney disease that affects the kidney’s glomeruli, which is where small molecules are first filtered out of blood and into the urine.

From the name, you have glomerulosclerosis, which indicates sclerosis, or scar tissue, forming in the glomeruli.

Segmental means that only a segment, or part of the glomeruli is affected, and focal means that among all those glomeruli in the kidney, only some are affected.

Those glomeruli that are affected, though, allow proteins to filter through into the urine, and ultimately people with FSGS develop nephrotic syndrome.

But what exactly is nephrotic syndrome? Well usually the glomerulus only lets small molecules, like sodium and water, move from the blood into the kidney nephron, where it eventually makes its way into the urine. But with nephrotic syndromes, the glomeruli are damaged and they become more permeable, so they start letting plasma proteins come across from the blood to the nephron and then into the urine, which causes proteinuria, typically greater than 3.5 grams per day.

An important protein in the blood is albumin, and so when it starts leaving the blood, people get hypoalbuminemia—low albumin in the blood.

With less protein in the blood the oncotic pressure falls, which lowers the overall osmotic pressure, which drives water out of the blood vessels and into the tissues, called edema.

Finally, it’s thought that as a result of either losing albumin or losing some protein or proteins that inhibit the synthesis of lipids, or fat, you get increased levels of lipids in the blood, called hyperlipidemia.

Just like the proteins, these lipids can also get into the urine, causing lipiduria.

And those are the hallmarks of nephrotic syndrome—proteinuria, hypoalbuminemia, edema, hyperlipidemia, and lipiduria.

So focal segmental glomerulosclerosis is a type of nephrotic syndrome, that’s helpful, but why does the glomerulus develop segmental sclerosis in the first place?

Well, primary FSGS is when it’s idiopathic, or there’s no clear underlying cause.

What is known, though, is that the podocytes, which are the cells that have these long tentacle-like projections, called foot processes, that wrap around the capillaries in the glomeruli, are damaged. These damaged podocytes allow some plasma proteins and lipids to sneak by, which then go on to get into the urine.

Not only that though, over time, some of these proteins and lipids to get trapped and build up in the glomerulus, resulting in hyalinosis, where the tissue has a hyaline or glassy appearance on histology, and it’s thought that over time these areas move on to develop sclerosis, or scar tissue.

Key Takeaways

Focal segmental glomerulosclerosis (FSGS) is a cause of nephrotic syndrome in children and adolescents, as well as a leading cause of kidney failure in adults. It accounts for about a sixth of the cases of nephrotic syndrome.